共 18 条
[1]
Henderson-Smart D.J., Steer P., Methylxanthine treatment for apnea in preterm infants, Cochrane Database Syst. Rev, 2, (2000)
[2]
Shannon D.C., Gotay F., Stein I.M., Rogers M.C., Todres I.D., Moylan F.M.B., Prevention of apnea and bradycardia in low-birthweight infants, Pediatrics, 55, pp. 589-594, (1975)
[3]
Aranda J.V., Turmen T., Methylxanthines in apnea of prematurity, Clin. Perinatol, 6, 1, pp. 87-108, (1979)
[4]
Muttitt S.C., Tierney A.J., Finer N.N., The dose response of theophylline in the treatment of apnea of prematurity, J. Pediatr, 112, pp. 115-121, (1988)
[5]
Siberry G.K., Iannone R., The Harriet Lane Handbook, pp. 625-626, (2000)
[6]
Young T.E., Mangum B., Neofax, pp. 160-161, (2001)
[7]
Bhatt D.R., Reber D.J., Wirtschafter D.D., Parikh A.N., Thomas J.C., Neonatal Drug Formulary, pp. 20-22, (1997)
[8]
Taketomo C.K., Hodding J.H., Kraus D.M., Pediatric Dosage Handbook, pp. 61-63, (2000)
[9]
Gal P., Gilman J.T., Concerns about the food and drug administration guidelines for neonatal theophylline dosing, Ther. Drug Monit, 8, 1, pp. 1-3, (1986)
[10]
Maxwell-Rubin M., Paap C.M., Godley P.J., Adequacy of recommended aminophylline loading doses in children, Am. J. Hosp. Pharm, 51, pp. 1667-1671, (1994)